Back to search

The Effect of Adding Exenatide to a Thiazolidinedione in Suboptimally Controlled Type 2 Diabetes

Data up to Jan 2025

Published2007
Citations436
References33

Total Citations Per Year

Abstract

References (33)

Statistical Analysis With Missing Data

1989 • 18,117 citations

Use and Abuse of HOMA Modeling

2004 • 4,678 citations

Linear Mixed Models for Longitudinal Data

1997 • 3,557 citations

Effects of Exenatide (Exendin-4) on Glycemic Control and Weight Over 30 Weeks in Metformin-Treated Patients With Type 2 Diabetes

2005 • 1,541 citations

Contributions of Fasting and Postprandial Plasma Glucose Increments to the Overall Diurnal Hyperglycemia of Type 2 Diabetic Patients

2003 • 1,441 citations

Effects of Exenatide (Exendin-4) on Glycemic Control Over 30 Weeks in Sulfonylurea-Treated Patients With Type 2 Diabetes

2004 • 1,329 citations

Pharmacologic Therapy for Type 2 Diabetes Mellitus

1999 • 1,196 citations

Effects of Exenatide (Exendin-4) on Glycemic Control Over 30 Weeks in Patients With Type 2 Diabetes Treated With Metformin and a Sulfonylurea

2005 • 1,170 citations

Exenatide versus Insulin Glargine in Patients with Suboptimally Controlled Type 2 Diabetes

2005 • 804 citations

Efficacy and Metabolic Effects of Metformin and Troglitazone in Type II Diabetes Mellitus

1998 • 798 citations

Glycemic Control From 1988 to 2000 Among U.S. Adults Diagnosed With Type 2 Diabetes

2004 • 672 citations

Thiazolidinedione Use, Fluid Retention, and Congestive Heart Failure

2004 • 578 citations

Enhancing Incretin Action for the Treatment of Type 2 Diabetes

2003 • 578 citations

Synthetic Exendin-4 (Exenatide) Significantly Reduces Postprandial and Fasting Plasma Glucose in Subjects with Type 2 Diabetes

2003 • 556 citations

Postprandial Blood Glucose Is a Stronger Predictor of Cardiovascular Events Than Fasting Blood Glucose in Type 2 Diabetes Mellitus, Particularly in Women: Lessons from the San Luigi Gonzaga Diabetes Study

2006 • 550 citations

Effect of Metformin and Rosiglitazone Combination Therapy in Patients With Type 2 Diabetes Mellitus

2000 • 547 citations

Exendin-4 reduces fasting and postprandial glucose and decreases energy intake in healthy volunteers

2001 • 469 citations

Pharmacology of exenatide (synthetic exendin-4): a potential therapeutic for improved glycemic control of type 2 diabetes

2003 • 451 citations

Interim analysis of the effects of exenatide treatment on A1C, weight and cardiovascular risk factors over 82 weeks in 314 overweight patients with type 2 diabetes

2006 • 427 citations

Pharmacokinetics, pharmacodynamics, and safety of exenatide in patients with type 2 diabetes mellitus

2005 • 424 citations

Effect of Intravenous Infusion of Exenatide (Synthetic Exendin-4) on Glucose-Dependent Insulin Secretion and Counterregulation During Hypoglycemia

2004 • 253 citations

Insulinotropic actions of exendin-4 and glucagon-like peptide-1 in vivo and in vitro

2001 • 247 citations

The Insulinotropic Effect of Acute Exendin-4 Administered to Humans: Comparison of Nondiabetic State to Type 2 Diabetes

2002 • 244 citations

Weight Effect of Current and Experimental Drugs for Diabetes Mellitus

2003 • 113 citations

Glycemic control with Glyburide/Metformin tablets in combination with rosiglitazone in patients with type 2 diabetes: a randomized, double-blind trial

2004 • 109 citations

Recent Antihyperglycemic Prescribing Trends for U.S. Privately Insured Patients With Type 2 Diabetes

2003 • 107 citations

Rapid Increase in the Use of Oral Antidiabetic Drugs in the United States, 1990–2001

2003 • 107 citations

Exenatide Improves Glycemic Control and Reduces Body Weight in Subjects with Type 2 Diabetes: A Dose-Ranging Study

2005 • 104 citations

Pharmacology of exenatide (synthetic exendin-4) for the treatment of type 2 diabetes.

2003 • 85 citations

A comparison of the effects of thiazolidinediones and metformin on metabolic control in patients with type 2 diabetes mellitus

2004 • 61 citations

Progress with thiazolidinediones in the management of type 2 diabetes mellitus

2004 • 55 citations

Thiazolidinediones

2006 • 38 citations

Effects of thiazolidinediones for early treatment of type 2 diabetes mellitus.

2002 • 11 citations

Cited By (0)

Loading...